Jonathan Davies

Following Recent Policy Statement, FTC 'Disputes' 100+ Patent Listings In FDA Orange Book

Inconsistent Positions At FDA And USPTO Render Patent Unenforceable

Orange Book Transparency Act Creates Some New Obligations

New Law Establishes Purple Book Patent Disclosure Requirement